DE3854160D1 - Mit regressionsassoziierten antigenen in zusammenhangstehende methoden und verbindungen. - Google Patents

Mit regressionsassoziierten antigenen in zusammenhangstehende methoden und verbindungen.

Info

Publication number
DE3854160D1
DE3854160D1 DE3854160T DE3854160T DE3854160D1 DE 3854160 D1 DE3854160 D1 DE 3854160D1 DE 3854160 T DE3854160 T DE 3854160T DE 3854160 T DE3854160 T DE 3854160T DE 3854160 D1 DE3854160 D1 DE 3854160D1
Authority
DE
Germany
Prior art keywords
regression
raas
antibodies
raabs
regression associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3854160T
Other languages
English (en)
Inventor
George Fareed
Arup Sen
Pradip Ghosh-Dastidar
Alvin Liu
Jar-How Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Genetic Engineering Inc
Original Assignee
International Genetic Engineering Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Genetic Engineering Inc filed Critical International Genetic Engineering Inc
Application granted granted Critical
Publication of DE3854160D1 publication Critical patent/DE3854160D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE3854160T 1987-09-16 1988-09-16 Mit regressionsassoziierten antigenen in zusammenhangstehende methoden und verbindungen. Expired - Lifetime DE3854160D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9791087A 1987-09-16 1987-09-16
US13181587A 1987-12-11 1987-12-11
PCT/US1988/003222 WO1989005306A1 (en) 1987-09-16 1988-09-16 Method and compositions relating to regression-associated antigens

Publications (1)

Publication Number Publication Date
DE3854160D1 true DE3854160D1 (de) 1995-08-17

Family

ID=26793782

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3854160T Expired - Lifetime DE3854160D1 (de) 1987-09-16 1988-09-16 Mit regressionsassoziierten antigenen in zusammenhangstehende methoden und verbindungen.

Country Status (5)

Country Link
EP (2) EP0308265A3 (de)
AT (1) ATE124958T1 (de)
AU (1) AU625858B2 (de)
DE (1) DE3854160D1 (de)
WO (1) WO1989005306A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233441T2 (de) * 1991-04-26 2005-10-13 Osaka Bioscience Institute, Suita Menschliches Zelloberflächen-Antigen codierende DNA
JP3385408B2 (ja) * 1992-05-14 2003-03-10 株式会社林原生物化学研究所 新規蛋白質とその抗体、並びにその新規蛋白質の製造方法
US10996222B2 (en) 2014-12-05 2021-05-04 Boehringer Ingelheim Animal Health USA Inc. Enzyme-linked immunosorbent assay (ELISA) for the detection of anti-mycoplasma hyorhinis IgG in swine serum
CN108070560A (zh) * 2016-11-15 2018-05-25 江苏齐氏生物科技有限公司 一种人原代胃癌细胞的分离及培养方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187512A (en) * 1966-08-05 1970-04-08 Kyowa Hakko Kogyo Kk Process for Extracting Proteins from Micro-Organisms
US4100149A (en) * 1975-08-28 1978-07-11 Rhone-Poulenc Industries Method of separating proteins by ion exchange
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
US4705677A (en) * 1977-05-03 1987-11-10 Makari Jack G Immunization
US4863853A (en) * 1982-04-21 1989-09-05 Bartos Patent Development And Holding Company Limited Method of determining the diagnostic value of monitoring serum-CEA-levels in a carcinoma patient undergoing therapy
US4562160A (en) * 1983-04-01 1985-12-31 Sloan-Kettering Institute Melanoma tumor antigen and autologous antibody
US4746539A (en) * 1983-11-23 1988-05-24 The Ohio State University Research Foundation Purification of cancer-associated protein and preparation of antibody thereto
US4568488A (en) * 1984-01-11 1986-02-04 Lee Huang Sylvia Reverse immunoaffinity chromatography purification method
US4748112A (en) * 1986-03-07 1988-05-31 International Genetic Engineering, Inc. Methods and compositions relating to regression-associated antigens

Also Published As

Publication number Publication date
ATE124958T1 (de) 1995-07-15
WO1989005306A1 (en) 1989-06-15
EP0390798B1 (de) 1995-07-12
AU2613588A (en) 1989-07-05
AU625858B2 (en) 1992-07-16
EP0390798A1 (de) 1990-10-10
EP0308265A2 (de) 1989-03-22
EP0390798A4 (en) 1991-03-20
EP0308265A3 (de) 1991-02-06

Similar Documents

Publication Publication Date Title
Karanikas et al. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
DK1231268T3 (da) Polyklonale antistofbiblioteker
ATE91629T1 (de) Adhesin-antigene, antikoerper und dns-fragmente die das antigen kodieren, verfahren und mittel zur diagnose und immunisierung, usw.
DK0444181T3 (da) C-erbB-2 eksternt domæne: gp75
ATE118821T1 (de) Nukleotidesequenzen, die ein protein mit ureareaktivität kodieren.
HU901927D0 (en) Polymerized antibodies and process for their production
NO883763D0 (no) Terapeutiske blandinger mot streptokokkinfeksjoner, transformerte verter, fremgangsmaater ved immunisering og genespleisingsprodukter.
Ogata et al. Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody.
EP0353814A3 (de) Synthetische Peptide mit immunologischer Wirkung, welche die Herstellung von Antikörpern mit hoher Spezifizität gegen alpha-Fetoprotein fördern, und deren Benutzung auf diagnostischem Gebiet
ATE354656T1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
DK656687A (da) Bakterielle antigener, antistoffer, vacciner og fremgangsmaade til fremstilling deraf
DE3854160D1 (de) Mit regressionsassoziierten antigenen in zusammenhangstehende methoden und verbindungen.
FI900230A0 (fi) Anti-idiotypa antikroppar mot antikroppar mot antigener med hoeg molekylvikt associerade till human melanoma.
HUT52819A (en) Process for producing polypeptides suitable for diagnosing mycoplasmic contamination of swine, by way of recombinant dna technique
ATE86633T1 (de) Snrnp-a-antigen und fragmente davon.
NO861577L (no) Antigen, antistoff og fremgangsmaate for dets fremstilling og anvendelse derav for diagnostisering.
Chen et al. Chymotrypsin C and papain fragments of human immunoglobulin M
EP0237252A3 (de) Verfahren und Zusammensetzungen betreffend regressions-assoziierte Antigene
ATE133075T1 (de) Verwendung von antikörper gegen angiogenin: immunotherapeutische mittel
ATE140233T1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
ATE87316T1 (de) Von protein ps2 abgeleitete peptide.
ATE86261T1 (de) Tumorassoziiertes antigen.
Ballinari et al. Biochemical analysis of a public H‐2 specificity revealed by an anomalous reaction of an alloantiserum with a chemically induced C57BL/10 fibrosarcoma
Imai et al. Adenocarcinoma-Associated YH206 Antigen in the Sera of Cancer Patients
FI961439A (fi) Menetelmä terapeuttisesti käyttökelpoisen vasta-aineen tai vasta-ainefragmentin valmistamiseksi

Legal Events

Date Code Title Description
8332 No legal effect for de